Are you sure you want to log out?
Background: Preeclampsia is a major health problem causing increased perinatal and maternal morbidity and mortality. The presence of antiphospholipid antibodies is associated with pregnancy induced complications such as pregnancy induced hypertension, preeclampsia, eclampsia, preterm delivery, maternal death, intrauterine growth restriction and stillbirth. However, their role in the pathogenesis of Preeclampsia and if its presence in Preeclampsia worsen pregnancy outcome has remained an issue of controversy. Objective: To determine the association of APLA with pregnancy outcome in women presenting with preeclampsia. Design: A cross sectional study. Methodology: In this study, 50 participants with Preeclampsia served as cases, while 50 normotensive pregnant participants above 20 weeks of gestation matched for gestational age and parity served as control. The antiphospholipid antibodies levels and pregnancy outcomes were compared between the cases and control. Pregnancy outcomes were also compared with APLA levels among preeclamptic participants. These participants were recruited from the antenatal clinic and the delivery suite of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi. Data were analyzed using the chisquare, student t2 test, Mann Whitney U test